- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 14 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.4: 12 residues within 4Å:- Chain D: T.215, D.217, K.258, V.260, L.267, N.268, R.383, T.447, C.448, K.449, S.450
- Ligands: NAG.26
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:D.217
- Hydrogen bonds: D:T.215, D:D.217
NAG-NAG-BMA-MAN-MAN.9: 9 residues within 4Å:- Chain I: D.217, V.260, L.267, N.268, N.381, R.383, K.449, S.450
- Ligands: NAG.36
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:D.217
NAG-NAG-BMA-MAN-MAN.13: 11 residues within 4Å:- Chain M: T.215, D.217, V.260, L.267, N.268, N.381, R.383, C.448, K.449, S.450
- Ligands: NAG.46
3 PLIP interactions:3 interactions with chain M- Hydrogen bonds: M:D.217, M:R.383, M:K.449
- 29 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.18: 3 residues within 4Å:- Chain A: X.96
- Chain D: R.190, N.193
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain D: N.307, I.328
- Ligands: NAG.25
Ligand excluded by PLIPNAG.20: 5 residues within 4Å:- Chain D: T.133, E.135, S.160, F.161, N.162
Ligand excluded by PLIPNAG.21: 5 residues within 4Å:- Chain D: N.236, K.237, T.238, N.240, N.246
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain D: N.240, T.242, S.280
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain D: N.282, T.284, N.285
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain D: S.392, S.393, N.396
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain D: P.305, N.445
- Ligands: NAG.19
Ligand excluded by PLIPNAG.26: 5 residues within 4Å:- Chain D: N.268, K.449, S.450, N.451
- Ligands: NAG-NAG-BMA-MAN-MAN.4
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain F: X.96
- Chain I: R.190, N.193
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain I: N.307, I.328
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain I: N.158, Y.175, L.177, D.326
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain I: T.133, S.160, F.161, N.162
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain I: N.236, K.237, T.238, N.240
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain I: N.240, T.242, S.280
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain I: N.282, T.284, N.285
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain I: S.392, S.393, N.396
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain I: R.198, N.203, T.204
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain I: N.268, N.451
- Ligands: NAG-NAG-BMA-MAN-MAN.9
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain M: R.190, N.193
- Chain N: X.96
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain M: N.307, T.309, I.328
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain M: T.133, E.135, S.160, F.161, N.162
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain M: N.282, T.284, N.285
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain M: S.392, S.393, N.396
- Ligands: NAG-NAG.15
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain I: R.314
- Chain M: R.198, N.203, T.204
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain M: E.88, V.90, N.235, N.247
Ligand excluded by PLIPNAG.44: 7 residues within 4Å:- Chain M: W.101, N.240, G.241, T.242, G.243, P.244, S.280
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain M: N.236, T.238
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain M: N.268, N.451
- Ligands: NAG-NAG-BMA-MAN-MAN.13
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brown, S. et al., Anti-immune complex antibodies are elicited during repeated immunization with HIV Env immunogens. Sci Immunol (2025)
- Release Date
- 2025-01-29
- Peptides
- Rabbit V2 Polyclonal Antibody - Predicted Light Chain: AFN
Rabbit Anti-Immune Complex Antibody - Predicted Light Chain: BGK
Rabbit V2 Polyclonal Antibody - Predicted Heavy Chain: CHL
Surface protein gp120: DIM
Rabbit Anti-Immune Complex Antibody - Predicted Heavy Chain: EJR
Transmembrane protein gp41: OPQ - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
FN
NB
BG
GK
KC
CH
HL
LD
DI
IM
ME
EJ
JR
RO
OP
PQ
Q
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 14 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 29 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brown, S. et al., Anti-immune complex antibodies are elicited during repeated immunization with HIV Env immunogens. Sci Immunol (2025)
- Release Date
- 2025-01-29
- Peptides
- Rabbit V2 Polyclonal Antibody - Predicted Light Chain: AFN
Rabbit Anti-Immune Complex Antibody - Predicted Light Chain: BGK
Rabbit V2 Polyclonal Antibody - Predicted Heavy Chain: CHL
Surface protein gp120: DIM
Rabbit Anti-Immune Complex Antibody - Predicted Heavy Chain: EJR
Transmembrane protein gp41: OPQ - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
FN
NB
BG
GK
KC
CH
HL
LD
DI
IM
ME
EJ
JR
RO
OP
PQ
Q